메뉴 건너뛰기




Volumn 61, Issue 10, 2013, Pages 1122-1123

Why are we still using coronary bare-metal stents?

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

EID: 84875478486     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.11.049     Document Type: Letter
Times cited : (50)

References (6)
  • 1
    • 84868557288 scopus 로고    scopus 로고
    • The risk of cardiac and bleeding events following noncardiac surgery relative to antiplatelet therapy in patients with prior percutaneous coronary intervention
    • S. Singla, R. Sachdeva, B.F. Uretsky The risk of cardiac and bleeding events following noncardiac surgery relative to antiplatelet therapy in patients with prior percutaneous coronary intervention J Am Coll Cardiol 60 2012 2005 2016
    • (2012) J Am Coll Cardiol , vol.60 , pp. 2005-2016
    • Singla, S.1    Sachdeva, R.2    Uretsky, B.F.3
  • 2
    • 67650755016 scopus 로고    scopus 로고
    • Safety and efficacy of drug-eluting and bare metal stents: Comprehensive meta-analysis of randomized trials and observational studies
    • A.J. Kirtane, A. Gupta, S. Lyengar Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies Circulation 119 2009 3198 3206
    • (2009) Circulation , vol.119 , pp. 3198-3206
    • Kirtane, A.J.1    Gupta, A.2    Lyengar, S.3
  • 3
    • 77958128969 scopus 로고    scopus 로고
    • Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI)
    • W. Wijns, P. Kolh, N. Danchin Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 31 2010 2501 2555
    • (2010) Eur Heart J , vol.31 , pp. 2501-2555
    • Wijns, W.1    Kolh, P.2    Danchin, N.3
  • 4
    • 84855992555 scopus 로고    scopus 로고
    • 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the Society for Cardiovascular Angiography and Interventions
    • American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Society for Cardiovascular and Angiography Interventions
    • G.N. Levine, E.R. Bates, J.C. Blankenship American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines; Society for Cardiovascular and Angiography Interventions 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 e44 e122
    • (2011) J Am Coll Cardiol , vol.58
    • Levine, G.N.1    Bates, E.R.2    Blankenship, J.C.3
  • 5
    • 84860135329 scopus 로고    scopus 로고
    • Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial
    • M. Valgimigli, G. Campo, M. Monti Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial Circulation 125 2012 2015 2026
    • (2012) Circulation , vol.125 , pp. 2015-2026
    • Valgimigli, M.1    Campo, G.2    Monti, M.3
  • 6
    • 84867050148 scopus 로고    scopus 로고
    • A new strategy for discontinuation of dual antiplatelet therapy: The RESET trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)
    • B.K. Kim, M.K. Hong, D.H. Shin A new strategy for discontinuation of dual antiplatelet therapy: the RESET trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation) J Am Coll Cardiol 60 2012 1340 1348
    • (2012) J Am Coll Cardiol , vol.60 , pp. 1340-1348
    • Kim, B.K.1    Hong, M.K.2    Shin, D.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.